News Updates
More Articles
- Benefits of Integrating Patient Engagement with Diversity, Equity, and Inclusion in New Medical Product Development: A Call for Action
- Drug Shortages in the Global South: A Proposed Parallel Tech and Reg Transfer Framework
- Fair Pay for Patient Engagement: Navigating the Evolving Landscape of Remuneration
- Industry’s Window to Express Interest in Africa Continental Product Evaluation Pilot Closes End of February 2024
- The Importance of Regulatory Due Diligence During the Acquisition Process
Fair Pay for Patient Engagement: Navigating the Evolving Landscape of Remuneration
In response to collective calls to action, Patient Focused Medicines Development (PFMD) built upon previous collaborative work with the National Health Council (NHC) and the Workgroup of European Cancer Patient Advocacy Networks (WECAN) to outline practical solutions that support PE partners in navigating remuneration and in effectively applying fair market value (FMV) rates.
×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!